NCT04072445 2023-08-09
Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer
Mayo Clinic
Phase 2 Completed
Clinical Trials
3 trialsNCT02720601 2018-01-25
Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers
New Mexico Cancer Research Alliance
Phase 2 Withdrawn
NCT00003276 2016-07-06
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed